Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients

Revista Latinoamericana de Microbiologia

Volumn 44, Issue 2, 2002, Pages 65-68

  Paniagua C , Gloria Luz ^b   Monroy P , Eric ^b   Negrete A , Erasmo ^b   Vaca P , Sergio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b NONE

Author keywords

Antimycotic susceptibility; Candida; Oral candidiasis

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; MICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CHILD; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; THROAT CULTURE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FLUCYTOSINE; HUMANS; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; PHARYNX;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0042320831     PISSN: 01874640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anaissie, E.J., G.P. Bodey and M.G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 8:323-330.
2. Banerjee, S.N., T.G. Emori, D.H. Culver, R.P. Gaynes, W.R. Jarvis, T. Horan. J.R. Edwars, T. Tolson, T. Henderson and W.J. Marones. 1991. The National Nosocomial Infections Surveillance System. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91 (Suppl. 3B):86S-89S.
3. Barchiesi, F., A.L. Colombo, D.A. McGough, A.W. Fothergill, and M.G. Rinaldi. 1994. In vitro activity of new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:2553-2556.
4. Batura-Gabryel, N., U. Wiezorec and W. Mlynaiczyk. 1997. In vitro susceptibility of antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract. Pneumonol. Alergol. Pol. 65:355-359.
5. Conly, J., R. Rennie, J. Johnson, S. Farah and L. Hellman. 1992. Disseminated candidiasis due to amphotericin B-resistant Candida albicans. J. Infect. Dis. 165:761-764.
6. Dick, J., W. Merz and R. Sarai. 1980. Incidence of polyene resistant yeast recovered from clinical specimens. Antimicrob. Agents Chemother. 18:158-163.
7. Drouhet, E. and B. Dupont. 1987. Evolution of antifungal agents: Past, present and future. Rev. Infect. Dis. 9 (suppl. 1):S4-S14.
8. Fan-Harvard, P., D. Capano, S.M. Smith, A. Mangia and Eng R.H.K. 1991. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob. Agents Chemother. 35:2302-2305.
9. Galgiani, J.N.D.J. Drutz, D.S. Feingold, T.M. Kerkering, L.R. McCarthy, M.A. Saubolle and J.C. Sherris. 1985. Committee report. Antifungal susceptibility testing. National Committee for Clinical Laboratory Standards. Villanova. Pa. 5:433-481.
10. Gallis, R. R.H. Drew and W.W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
11. Hernández, M.L., C. Gil, J. Pla and C. Nombela. 1998. Induced expression of Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals. Yeast 14:517-526.
12. Law, D., C.B. Moore, H.M. Wardle, L.A. Ganguli, M.G. Keaney and D.W. Denning. 1994. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J. Antimicrob. Chemother. 34:659-668.
13. Maksymiuk, A.W., S. Thongprasert, R. Hopfer, M. Luna, V. Fainstein and G.P. Bodey. 1984. Systemic candidiasis in cancer patients. Am. J. Med. 77:20-27.
14. Monteil, R.A., I. Madinier, and Y. Le Fichoux. 1997. In vitro antifungal resistance of oral Candida albicans strains in non-AIDS patients. Oral Microbiol. Immunol. 12:126-128.
15. Radetsky, M., R.C. Wheeler, M.M. Roe and J.K. Todd. 1986. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome. J. Clin. Microbiol. 24:600-606.
16. Soll, D.R., R. Galask, J. Schmid, C. Hanna, H. Mac and B. Morrow. 1991. Genetic dissimilarity of commensal strains of Candida spp. Carried in different anatomical locations of the healthy women. J. Clin. Microbiol. 29:1702-1710.
17. Vazquez, J.A., M.T. Arganoza, D. Boikov, S. Yoon, J.D. Sobel and R.A. Akins.1998. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J. Clin. Microbiol. 36:2690-2695.
18. White, T.C. 1997. Increased mRNA levels of ERG16, CDR and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents. Chemother. 41:1482-1487.
19. Yoshida, T., K. Jono & K. Okonogi. 1997. Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds. Antimicrob. Agents Chemother. 41(6):1349-1351.